30
Views
34
CrossRef citations to date
0
Altmetric
Original Article

Physiological and Pathophysiological Aspects of Somatostatin

&
Pages 29-41 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

R. J. Lieverse, J. B. M. J. Jansen, A. A. M. Masclee & C. B. H. W. Lamers. (1993) Gastrointestinal Disturbances with Obesity. Scandinavian Journal of Gastroenterology 28:sup200, pages 53-58.
Read now
M. T. Zavy & T. O. Lindsey. (1988) Effect of cysteamine administration on growth and efficiency of food utilisation in chicks. British Poultry Science 29:2, pages 409-417.
Read now

Articles from other publishers (32)

Antonio Datola, Alessandra Pistacchio, Patrizia Simone, Lucia Colarusso, Maura Melchiorre, Gianluca Rinaldi, Maryam Amidi, Jane Politi & Gabriella Angiuoni. (2023) Characterization by LC–MS/MS of oxidized products identified in synthetic peptide somatostatin and cetrorelix submitted to forced oxidative stress by hydrogen peroxide: Two case studies. Journal of Mass Spectrometry 58:5.
Crossref
Jean Morisset. (2017) Somatostatin. Pancreas 46:1, pages 8-18.
Crossref
J. Roemmler, B. Steffin, B. Gutt, H.J. Schneider, C. Sievers, M. Bidlingmaier & J. Schopohl. (2010) The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment. Growth Hormone & IGF Research 20:5, pages 338-344.
Crossref
J. Roemmler, B. Steffin, B. Gutt, C. Sievers, M. Bidlingmaier & J. Schopohl. (2009) The effect of acute application of pegvisomant alone and in combination with octreotide on endogenous GH levels during a 6-h test in patients with acromegaly on constant pegvisomant treatment. Growth Hormone & IGF Research 19:3, pages 245-251.
Crossref
Frans C. SchuitPeter HuypensHarry HeimbergDaniel G. Pipeleers. (2001) Glucose Sensing in Pancreatic β-Cells. Diabetes 50:1, pages 1-11.
Crossref
ConceiçÃo Calhau, Fátima Martel, Cândido Hipólito-Reis & Isabel Azevedo. (2000) Differences between duodenal and jejunal rat alkaline phosphatase. Clinical Biochemistry 33:7, pages 571-577.
Crossref
Glen G. Briand & Neil Burford. (1999) Bismuth Compounds and Preparations with Biological or Medicinal Relevance. Chemical Reviews 99:9, pages 2601-2658.
Crossref
KapIc.oglu, Mollamehmetoglu, Kutlu, Can & Ozgur. (1998) Inhibition of penile erection in rats by a long-acting somatostatin analogue, octreotide (SMS 201-995). BJU International 81:1, pages 142-145.
Crossref
Maddalena Peracchi, F. Carola, F. Cavagnini, R. Benti, B. Bareggi, G. Baccalaro & G. Basilisco. (2014) Plasma somatostatin-like immunoreactivity and somatostatin-28 levels in obese men. Journal of Endocrinological Investigation 21:1, pages 20-23.
Crossref
Fiemu E. Nwariaku, Anthony Terracina, William J. Mileski, Joseph P. Minei & C.James Carrico. (1995) Is octreotide beneficial following pancreatic injury?. The American Journal of Surgery 170:6, pages 582-585.
Crossref
MIREK KAPUSCINSKI & ARTHUR SHULKES. (2008) Secretory and biosynthetic responses of gastrin and somatostatin to acute changes in gastric acidity. Journal of Gastroenterology and Hepatology 10:4, pages 405-412.
Crossref
N. Weigert, A. Schäffler, J. Reichenberger, S. Madaus, M. Classen & V. Schusdziarra. (1995) Effect of endogenous opioids on vagally induced release of gastrin, somatostatin and bombesin-like immunoreactivity from the perfused rat stomach. Regulatory Peptides 55:2, pages 207-215.
Crossref
K. L. CHAN, W. Y. LAU & J. Y. SUNG. (2008) Octreotide therapy for pancreaticopleural fistula. Journal of Gastroenterology and Hepatology 9:5, pages 530-532.
Crossref
M. ERIKSSON, E. BJÖRKSTRAND, U. SMEDH, P. ALSTER, A.‐S. MATTHIESEN & K. UVNÄS‐MOBERG. (2008) Role of vagal nerve activity during suckling. Effects on plasma levels of oxytocin, prolactin, VIP, somatostatin, insulin, glucagon, glucose and of milk secretion in lactating rats. Acta Physiologica Scandinavica 151:4, pages 453-459.
Crossref
Arthur Shulkes. (1994) 9 Somatostatin: physiology and clinical applications. Baillière's Clinical Endocrinology and Metabolism 8:1, pages 215-236.
Crossref
K.C.K. Lloyd, V. Maxwell, C.-N. Chuang, H.C. Wong, A.H. Soll & J.H. Walsh. (1994) Somatostatin is released in response to cholecystokinin by activation of type A CCK receptors. Peptides 15:2, pages 223-227.
Crossref
C. S. Chew. 1993. Gastrointestinal Regulatory Peptides. Gastrointestinal Regulatory Peptides 199 252 .
K.C.K. Lloyd, V. Maxwell, G. Ohning & J.H. Walsh. (1992) Intestinal fat does not inhibit gastric function through a hormonal somatostatin mechanism in dogs. Gastroenterology 103:4, pages 1221-1228.
Crossref
Juha Rouru, Risto Huupponen, Ullamari Pesonen & Markku Koulu. (1992) Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese zucker rats. Life Sciences 50:23, pages 1813-1820.
Crossref
Alan G. Harris. (2012) Octreotide in the Treatment of Disorders of the Gastrointestinal System. Drug Investigation 4:S3, pages 1-54.
Crossref
G. Cavallini, M. Filippini & P. Bovo. 1992. Pancreatic Fistulas. Pancreatic Fistulas 39 60 .
Y. C. Patel, J. Epelbaum, D. R. Rubinow, C. L. Davis, R. M. Post, V. Schusdziarra, P. N. Maton & R. F. ArakakiV. Schusdziarra. 1992. Somatostatin. Somatostatin 43 54 .
R. Eissele, I. Koop, M. Schaar, H. Koop & R. Arnold. (1991) Role of cholecystokinin in the control of gastric somatostatin in the rat: in vivo and in vitro studies. Regulatory Peptides 32:3, pages 333-340.
Crossref
Bruce H. Francis, Denis G. Baskin, David R. Saunders & John W. Ensinck. (1990) Distribution of somatostatin-14 and somatostatin-28 gastrointestinal-pancreatic cells of rats and humans. Gastroenterology 99:5, pages 1283-1291.
Crossref
A.-M. Widström, A.-S. Matthiesen, J. Winberg & K. Uvnäs-Moberg. (1989) Maternal somatostatin levels and their correlation with infant birth weight. Early Human Development 20:3-4, pages 165-174.
Crossref
Edwin E. Daniel, Stephen M. Collins, Jo‐Ann E. T. Fox & Jan D. Huizinga. 2011. Comprehensive Physiology. Comprehensive Physiology 759 816 .
G.S. Taylor & R.A.R. Bywater. (1989) Novel autonomic neurotransmitters and intestinal function. Pharmacology & Therapeutics 40:3, pages 401-438.
Crossref
T. M. O’Dorisio, T. S. Gaginella, M. S. O’Dorisio, R. W. Meleca, D. A. Wray & K. Osei. 1989. Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors. Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors 43 48 .
T. M. O'DORISIO, T. S. GAGINELLA, H. S. MEKHJIAN, B. RAO & M. S. O'DORISIO. (1988) Somatostatin and Analogues in the Treatment of VIPoma. Annals of the New York Academy of Sciences 527:1 Vasoactive In, pages 528-535.
Crossref
Michael J. Zdon, Thomas E. Adrian & Irvin M. Modlin. (1988) Gastric somatostatin release: Evidence for direct mediation by calcitonin gene-related peptide and vasoactive intestinal peptide. Journal of Surgical Research 44:6, pages 680-686.
Crossref
H.D. Allescher, V. Schusdziarra, N. Weigert & M. Classen. (1987) Interaction between endogenous opioids, cholinergic and adrenergic mechanisms during vagally-induced gastrin release in rats. Neuropeptides 9:4, pages 309-323.
Crossref
Volker Schusdziarra. 1987. Somatostatin. Somatostatin 209 217 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.